These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 14452103)

  • 1. Studies on the feasibility of adjuvant chemotherapy with 5-fluorouracil (FU) and 5-fluoro-2'-deoxyuridine (FUDR) in the immediate postoperative period.
    JOHNSON RO; WOLBERG WH; CURRERI AR
    Arch Surg; 1962 Jul; 85():81-4. PubMed ID: 14452103
    [No Abstract]   [Full Text] [Related]  

  • 2. A comparative study of 5-fluorouracil (FU), 5-fluorodeoxyuridine (FUDR), and methotrexate (MTX)-progress report.
    HALL TC
    Cancer Chemother Rep; 1962 Feb; 16():391-6. PubMed ID: 13903907
    [No Abstract]   [Full Text] [Related]  

  • 3. The clinical evaluation of 5-fluorouracil and 5-fluoro-2'-deoxyuridine in solid tumors in adults: a progress report.
    YOUNG CW; ELLISON RR; SULLIVAN RD; LEVICK SN; KAUFMAN R; MILLER E; WOLDOW I; ESCHER G; LI MC; KARNOFSKY DA; BURCHENAL JH
    Cancer Chemother Rep; 1960 Feb; 6():17-20. PubMed ID: 13846613
    [No Abstract]   [Full Text] [Related]  

  • 4. Effect of deoxyuridine coadministration on toxicity and antitumor activity of fluorouracil and floxuridine.
    Jato JG; Lake LM; Grunden EE; Johnson BM
    J Pharm Sci; 1975 Jun; 64(6):943-6. PubMed ID: 124347
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 5-Fluorouracil and derivatives in cancer chemotherapy. 3. In vivo enhancement of antitumor activity of 5-fluorouracil (FU) and 5-fluoro-2'-deoxyuridine (FUDR).
    Jato J; Windheuser JJ
    J Pharm Sci; 1973 Dec; 62(12):1975-8. PubMed ID: 4271579
    [No Abstract]   [Full Text] [Related]  

  • 6. Comparison of 5-fluorouracil and 5-fluoro-2'-deoxyuridine in the treatment of far-advanced breast and colon lesions.
    CURRERI AR; ANSFIELD FJ
    Cancer Chemother Rep; 1962 Feb; 16():387-8. PubMed ID: 13882717
    [No Abstract]   [Full Text] [Related]  

  • 7. A novel dimeric fluoropyrimidine molecule behaves as a remote precursor of 5-fluoro-2'-deoxyuridine in human erythrocytes.
    Gasparini A; Giovine M; Damonte G; Tonetti M; Grandi T; Mazzei M; Balbi A; Silvestro L; Benatti U; De Flora A
    Biochem Pharmacol; 1994 Sep; 48(6):1121-8. PubMed ID: 7945405
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A phase I trial of immediate postoperative intraperitoneal floxuridine and leucovorin plus systemic 5-fluorouracil and levamisole after resection of high risk colon cancer.
    Kelsen DP; Saltz L; Cohen AM; Yao TJ; Enker W; Tong W; Tao Y; Bertino JR
    Cancer; 1994 Oct; 74(8):2224-33. PubMed ID: 7922973
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative physiologic dispositions of 5-fluoro-2'-deoxyuridine and 5-fluorouracil in mice bearing solid L1210 lymphocytic leukemia.
    Chadwick M; Chang C
    Cancer Treat Rep; 1976 Jul; 60(7):845-55. PubMed ID: 137772
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of uracil and thymidine on the development of resistance to 5-fluorouracil in Pediococcus cerevisiae.
    WHITE PJ; NICHOL CA
    J Bacteriol; 1963 Jan; 85(1):97-105. PubMed ID: 14000344
    [TBL] [Abstract][Full Text] [Related]  

  • 11. THE EFFECT OF NATURAL AND UNNNATURAL PYRIMIDINES AND PYRIMIDINE NUCLEOSIDES ON THE PHOSPHOROLYSIS OF 5-IODODEOXYURIDINE BY MOUSE LIVER EXTRACT.
    KRISS JP; BOND SB
    Biochem Pharmacol; 1964 Mar; 13():365-70. PubMed ID: 14157596
    [No Abstract]   [Full Text] [Related]  

  • 12. Postoperative intraperitoneal 5-fluoro-2'-deoxyuridine added to chemoradiation in patients curatively resected (R0) for locally advanced gastric and gastroesophageal junction adenocarcinoma.
    Cohen DJ; Newman E; Iqbal S; Chang RY; Potmesil M; Ryan T; Donahue B; Chandra A; Liu M; Utate M; Hiotis S; Pachter LH; Hochster H; Muggia F
    Ann Surg Oncol; 2012 Feb; 19(2):478-85. PubMed ID: 21769462
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Important role of the dihydrouracil/uracil ratio in marked interpatient variations of fluoropyrimidine pharmacokinetics and pharmacodynamics.
    Jiang H; Lu J; Jiang J; Hu P
    J Clin Pharmacol; 2004 Nov; 44(11):1260-72. PubMed ID: 15496644
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potentiation by acyclothymidine esters of the antitumor effect of orally administered 5-fluoro-2'-deoxyuridine esters on L1210 in mice.
    Kawaguchi T; Saito M; Saneyoshi M
    Jpn J Cancer Res; 1986 May; 77(5):436-9. PubMed ID: 2942523
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potentiation of the antitumor effect of 5-fluoro-2'-deoxyuridine esters in combination with acyclothymidine esters on L1210 in mice via oral administration.
    Kawaguchi T; Saito M; Saneyoshi M
    J Pharm Sci; 1988 Nov; 77(11):939-43. PubMed ID: 2976090
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FURTHER CLINICAL COMPARISON BETWEEN 5-FLUOROURACIL (5-FU) AND 5-FLUORO-2' -DEOXYURIDINE (5-FUDR).
    ANSFIELD FJ; CURRERI AR
    Cancer Chemother Rep; 1963 Oct; 32():101-5. PubMed ID: 14088828
    [No Abstract]   [Full Text] [Related]  

  • 17. In vivo antitumor effects of fluoropyrimidines on colon adenocarcinoma 38 and enhancement by leucovorin.
    Iigo M; Nishikata K; Hoshi A
    Jpn J Cancer Res; 1992 Apr; 83(4):392-6. PubMed ID: 1387127
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The potentiation by 5-iodo-2'-deoxyuridine (IUDR) of the tumor-inhibitory activity of 5-fluoro-2'-deoxyuridine (FUDR).
    HEIDELBERGER C; GRIESBACH L; GHOBAR A
    Cancer Chemother Rep; 1960 Feb; 6():37-8. PubMed ID: 14400595
    [No Abstract]   [Full Text] [Related]  

  • 19. Ribose-transfer activity from uridine to 5-fluorouracil in Ehrlich ascites tumor cells.
    Nabeya Y; Isono K; Moriyama Y; Fujimura S
    Jpn J Cancer Res; 1990; 81(6-7):692-700. PubMed ID: 1698195
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systemic irinotecan or regional floxuridine chemotherapy prolongs survival after hepatic cryosurgery in patients with metastatic colon cancer refractory to 5-fluorouracil.
    Bilchik AJ; Wood TF; Chawla SP; Rose DM; Chung MH; Stern SS; Foshag LJ; Ramming KP
    Clin Colorectal Cancer; 2001 May; 1(1):36-42. PubMed ID: 12445377
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.